Egolix 200 Tablet

About Egolix 200 Tablet

Made by The ACME Laboratories Ltd., Egolix 200 is a tablet whose active ingredient is Elagolix. Egolix 200 is used to manage moderate to severe pain associated with endometriosis in women.

There are 8 brands of Elagolix listed in Bangladesh. The lowest listed price is Elagox 150 mg Tablet at ৳ 170.00 per unit.

What is Egolix 200 Tablet?

Egolix 200 200 mg tablet is a medicine made by The ACME Laboratories Ltd. The 200 mg strength is one available option. Elagolix belongs to the gonadotropin-releasing hormone (GnRH) antagonist class of medicines. Ask your doctor or pharmacist if you are unsure about it.

Uses of Egolix 200

Egolix 200 is used to manage moderate to severe pain associated with endometriosis in women. Endometriosis occurs when tissue similar to the lining of the uterus grows outside the uterus, often on the ovaries, fallopian tubes or other pelvic areas. Elagolix works by blocking a hormone receptor that helps control estrogen, which in turn may reduce the growth and activity of endometrial-like tissue outside the uterus. Ask your doctor whether it is right for your condition.

How to use Egolix 200

Before starting, pregnancy must be ruled out or treatment started within the first week of a menstrual period. Swallow the tablet with water. Egolix 200 is taken by mouth. Take Egolix 200 200 mg tablet exactly as your doctor prescribes. Your doctor will decide the dose, how often to take it and how long the course should last; never change these yourself. Do not change the dose or stop early without asking your doctor.

Side effects of Egolix 200

Common side effects reported with Elagolix include hot flushes and night sweats, headache, nausea, insomnia, missed periods, anxiety, joint pain and mood changes or depression-related symptoms. Because the medicine can affect mood, patients should tell their doctor about any new or worsening depression, anxiety or thoughts of self-harm. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

It is not recommended for women with known osteoporosis or severe liver problems, or with certain other medicines. Bone density should be assessed in women with additional risk factors for bone loss. Egolix 200 is contraindicated during pregnancy and may increase the risk of early pregnancy loss, so pregnancy must be excluded before starting and effective non-hormonal contraception used during treatment. Tell your doctor about depression, mood problems, liver disease or other medicines you take, including hormonal contraceptives.

Frequently asked questions

Why is Egolix 200 prescribed?

Egolix 200 is used to manage moderate to severe pain associated with endometriosis in women. Endometriosis occurs when tissue similar to the lining of the uterus grows outside the uterus, often on the ovaries, fallopian tubes or other pelvic areas.

How should I take Egolix 200?

Before starting, pregnancy must be ruled out or treatment started within the first week of a menstrual period. Swallow the tablet with water.

Can Egolix 200 cause side effects?

Common side effects reported with Elagolix include hot flushes and night sweats, headache, nausea, insomnia, missed periods, anxiety, joint pain and mood changes or depression-related symptoms. Because the medicine can affect mood, patients should tell their doctor about any new or worsening depression, anxiety or thoughts of self-harm.

Can I use Egolix 200 in pregnancy or while breastfeeding?

It is not recommended for women with known osteoporosis or severe liver problems, or with certain other medicines. Bone density should be assessed in women with additional risk factors for bone loss.

Indications

Elagolix is indicated for the management of moderate to severe pain associated with endometriosis.

Pharmacology

Endometriosis develops when tissue that is similar to the kind that is normally located in the uterus starts to grow outside of the uterus. Such growth leads to various symptoms like pain during periods, pelvic pain between periods, and pain during sexual intercourse. The growths themselves are referred to as lesions and frequently develop on the ovaries, fallopian tubes, and other areas around the uterus, including the bowel or bladder. The growth of these lesions is dependent upon the estrogen hormone.

Elagolix is an orally-administered, nonpeptide small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland Label. Administration of elagolix results in dose-dependent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased blood concentrations of the ovarian sex hormones, estradiol and progesterone.

Dosage & Administration

Exclude pregnancy before starting Elagolix or start Elagolix within 7 days from the onset of menses. Take Elagolix at approximately the same time each day, with or without food.

Initiate treatment with Elagolix 150 mg once daily-
  • Maximum Treatment Duration: 24 months
  • Coexisting Condition: None
Consider initiating treatment with Elagolix 200 mg twice daily-
  • Maximum Treatment Duration: 6 months
  • Coexisting Condition: Dyspareunia
Initiate treatment with Elagolix 150 mg once daily. Use of 200 mg twice daily is not recommended-
  • Maximum Treatment Duration: 6 months
  • Coexisting Condition: Moderate hepatic impairment (Child-Pugh Class B)

Interaction

May potentiate P-gp substrates (eg. Digoxin), CYP2C19 substrates (eg. Dose limit of Omeprazole is upto 40mg daily). May antagonize CYP3A substrates. Antagonizes oral Midazolam, Rosuvastatin; consider increasing their doses. Maybe antagonized by CYP3A inducers. Reduces efcacy with estrogen-containing contraceptives.

Contraindications

Elagolix is contraindicated in women:
  • Who are pregnant
  • Exposure to ORILISSA early in pregnancy may increase the risk of early pregnancy loss.
  • With known osteoporosis because of the risk of further bone loss
  • With severe hepatic impairment because of the risk of bone loss
  • With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil)

Side Effects

Most common adverse reactions (>5%) in clinical trials included hot flushes and night sweats, headache, nausea, insomnia, amenorrhea, anxiety, arthralgia, depression-related adverse reactions and mood changes.

Pregnancy & Lactation

Exposure to Elagolix early in pregnancy may increase the risk of early pregnancy loss. Use of Elagolix is contraindicated in pregnant women. Discontinue Elagolix if pregnancy occurs during treatment. The limited human data with the use of Elagolix in pregnant women are insufficient to determine whether there is a risk for major birth defects or miscarriage. Although two cases of congenital malformations were reported in clinical trials with Elagolix, no pattern was identified and miscarriages were reported at a similar incidence across treatment groups. There is no information on the presence of elagolix or its metabolites in human milk, the effects on the breastfed child, or the effects on milk production.

There are no adequate animal data on the excretion of Elagolix in milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Elagolix and any potential adverse effects on the breastfed child from Elagolix.

Precautions & Warnings

  • Bone Loss: Dose- and duration-dependent decreases in bone mineral density (BMD) that may not be completely reversible. Assess BMD in women with additional risk factors for bone loss
  • Reduced Ability to Recognize Pregnancy: Elagolix may alter menstrual bleeding, which may reduce the ability to recognize pregnancy. Perform testing if pregnancy is suspected. Discontinue if pregnancy is confirmed
  • Suicidal Ideation and Mood Disorders: Advise patients to seek medical attention for suicidal ideation, suicidal behavior, new onset or worsening depression, anxiety, or other mood changes
  • Hepatic Transaminase Elevations: Dose-dependent elevations in serum alanine aminotransferase (ALT). Counsel patients on signs and symptoms of liver injury
  • Potential for Reduced Efficacy with Estrogen-Containing Contraceptives: Use non-hormonal contraception during treatment and for one week after discontinuing Elagolix.

Overdose Effects

In case of overdose, patients should be monitored for any signs or symptoms of adverse reactions and initiate appropriate symptomatic treatment, as needed.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Elagolix

Other brands with the same generic name, cheapest first.

Elagox Tablet

150 mg

Elagolix

Nuvista Pharma Ltd

৳ 170.00 per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.